V.V. BLINOVA¹, E.A. PANTELEEVA², I.N. KONOVALOVA², A.A. MIRONOVA², E.S. BALABAEVA¹

 ¹Saratov State Medical University, Saratov, Russian Federation

²Regional Clinical Cardiology Dispensary, Saratov, Russian Federation

 Contact details:

Blinova V.V. ― PhD (medicine), Assistant of the Department of Therapy, Gastroenterology and Pulmonology

Address: 112 Bolshaya Kazachya St., Saratov, Russian Federation, 410012, e-mail: blinowa.viky@yandex.ru

 Objective: to provide a brief review of the literature and the clinical case of diagnosis in a patient with Brugada syndrome.

Material and methods: literary sources and medical records of a patient with Brugad syndrome (inpatient card) were studied.

Results: a brief review of the medical literature on Brugada syndrome is presented, the clinical characteristics of the patient’s disease are given, data from his laboratory and instrumental studies are presented, and the differential diagnosis of this pathology with acute coronary syndrome is demonstrated.

Conclusion: despite the rare occurrence of Brugada syndrome in the population, its timely diagnosis is possible in the symptomatic type due to the specific clinical picture, which was presented in this clinical case.

Key words: Brugada syndrome, acute coronary syndrome, right bundle branch block.

REFERENCES

1. Bokeriya L.A., Bokeriya O.L., Kirtbaya L.N. Brugada syndrome: cellular mechanisms and approaches to treatment. Annaly aritmologii, 2010, no. 3, pp. 45-49 (in Russ.).
2. Priori S.G., Wilde A.A., Horie M., Cho Y., Behr E.R., Berul C., Blom N., Brugada J., Chiang C.E., Huikuri H., Kannankeril P., Krahn A., Leenhardt A., Moss A., Schwartz P.J., Shimizu W., Tomaselli G., Tracy C. Executive summary: HRS/EHRA/ APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. Heart Rhythm., 2013; 10 (12): e85-108.
3. Brugada P., Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J. Am. Coll. Cardiol, 1992, vol. 20, pp. 1391-1396.
4. Brugada P., Brugada J., Brugada R. et al. Brugada Syndrome: 1992-2002: a historical perspective. J. Am. Coll. Cardiol, 2003, vol. 41(10), pp. 1665-1671.
5. Chen Q., Kirsch G.E., Zhang D. et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature, 1998, vol. 392, pp. 293-296.
6. McNair W.P., Ku L., Taylor M.R. et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation. 2004, vol. 110, 2163 p.
7. Olson T., Michels V., Ballew J. et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA, 2005, vol. 293, pp. 447-55.
8. Donohue D., Tehrani F., Jamehdor R., Lam C., Movahed M.R. The prevalence of Brugada ECG in adult patients in a large university hospital in the Western United States. Am Heart Hosp J, 2008, vol. 6, pp. 48-50.
9. Sarkozy A., Paparella G., Boussy T., Casado-Arroyo R., Yaza-ki Y., Chierchia G.B., De Asmundis C., Bayrak F., Namdar M., Richter S., Brugada J., Brugada P. The usefulness of the consensus clinical diagnostic criteria in Brugada syndrome. Int. J. Cardiol, 2013, vol. 167, no. 6, pp. 2700-4.
10. Hermida J.S., Lemoine J.L., Aoun F.B. et al. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol, 2000, vol. 86, pp. 91-94.
11. Bokeriya L.A., Revishvili A.Sh., Pronicheva I.V., Zaklyaz’minskaya E.V., Polyakov A.V. Clinical variability and approaches to the treatment of life-threatening ventricular arrhythmias caused by mutations in the SCN5A gene. Vestnik Rossiyskoy akademii meditsinskikh nauk, 2007, vol. 5, pp. 3-11 (in Russ.).
12. Brugada R., Brugada J., Antzelevitch C. et. al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation, 2000, vol. 101, rr. 510-515.
13. Tokioka K., Kusano K.F., Morita H. et al. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities. J. Am. Coll. Cardiol., 2014, vol. 63, no. 20, pp. 2131-2138.
14. Morito H., Kusano K.F., Minra D. et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada Syndrome. Circulation, 2008, vol. 118, rr. 1697-1704.
15. Moiseev V.S., Kiyakbaev G.K. Sindrom Brugada [Brugada syndrome]. Kardiomiopatii i miokardity. Moscow: GEOTAR-Media, 2011. Pp. 119-128.
16. Bezzina C., Barc J., Mizusawa Y. et al. Common variants at SCN5A-SCN10A and HEY2 are associated with brugada syndrome, a rare disease with high risk of sudden cardiac death. Nature genetics, 2013, vol. 45 (9), pp. 1044-1049.
17. Tadros R., Cadrin-Tourigny J., Abadir S., Rivard L., Nattel S., Talajic M., Khairy P. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application. Expert Rev. Cardiovasc. Ther, 2015, vol. 20, pp. 1-14.
18. Bokeriya L.A., Pronicheva L.V., Serguladze S.Yu., Lomidze N.N., Tembotova Zh.Kh., Kotanova E.S. Diagnostic experience and ten-year results of treatment of patients with Brugada syndrome. Analy aritmologii, 2017, vol. 14, no. 2 (in Russ.), available at: https://cyberleninka.ru/article/n/opyt-diagnostiki-i-desyatiletnie-rezultaty-lecheniya-patsientov-s-sindromom-brugada (accessed on: 1.12.18).